Overview
Updated 14 Jul 2026
Paul Barr, MD, is Professor of Medicine at University of Rochester Medical Center / Wilmot Cancer Institute. The public record shows 837 publications with 23,366 citations (h-index 55), centered on Hematology. It also documents an investigator role on 32 registered clinical trials, industry payments reported by 21 companies, 1 NIH-funded awards (2019–2026).
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Hematology
- 32 registered trials on ClinicalTrials.gov
- Open Payments reporting from 21 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 37 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 32 registered studies on ClinicalTrials.gov. The most recent:
- Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?
Sponsor: Trustees of Dartmouth College
InvestigatorNot, yet, recruitingNCT07454733 - Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Sponsor: Alliance for Clinical Trials in Oncology
InvestigatorPhase 3RecruitingNCT07321652 - Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2RecruitingNCT06672146
Industry payments
Updated 14 Jul 2026
21 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
- Janssen Biotech, Inc.Program year20252 payments
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2019–2026 per NIH RePORTER. The latest:
- Rochester Network Lead Academic Participating Site
University of Rochester
FY2026$1,186,097UG1CA233230 - The Role of Visit Audio Recordings in Triadic Dementia Care
Dartmouth College
FY2026$759,566R01AG077113 - The effect of clinic visit audio recordings for self-management in older adults
Dartmouth College
FY2026$640,587R01AG074959
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Wilmot Cancer Center, Strong Memorial Hospital, 90 Crittenden Boulevard, Rochester, NY 14642
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
Editorial & leadership rolesjournal and society appointments
- Member
Lymphoma Committee, Southwest Oncology Group (SWOG)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →urmc.rochester.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urmc.rochester.edu ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- Researcher Spotlight profile
Lymphoma Research Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lymphoma.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/cotainc_paul-barr-md-discusses-current-research-activity-6981607259755716608-nCXn
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Other
lymphoma.org/researcher-spotlight-paul-barr
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lymphoma.org ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christopher Ritchlin, MD
University of Rochester Medical Center
- 505
- publications
- 67
- h-index
- 11
- trials
Jonathan Steinberg, MD
University of Rochester Medical Center
- 379
- publications
- 69
- h-index
- 6
- trials
Jennifer Anolik, MD
University of Rochester Medical Center
- 197
- publications
- 53
- h-index
- 1
- trial